PON1 and familial hyperaldosteronism: This is the first study of PON1 activity and region polymorphisms coding in a family with FH with LDLR mutation, although in a couple of recent studies, the role of rs662 was assessed in relation to serum lipid levels and coronary artery disease (Liang, 2016; Chen et al., 2017).